These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37164893)

  • 21. Performance of Baveno VI and Expanded Baveno VI Criteria for Excluding High-Risk Varices in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis.
    Stafylidou M; Paschos P; Katsoula A; Malandris K; Ioakim K; Bekiari E; Haidich AB; Akriviadis E; Tsapas A
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1744-1755.e11. PubMed ID: 31077823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatosplenic shear wave elastography for prediction of esophageal varices in cirrhosis: a promising future?
    Pessoa ACSP; Silva CABD
    Rev Assoc Med Bras (1992); 2021 Jul; 67(7):913-915. PubMed ID: 34817498
    [No Abstract]   [Full Text] [Related]  

  • 23. Non-Invasive Prediction of High-Risk Varices in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
    Moctezuma-Velazquez C; Saffioti F; Tasayco-Huaman S; Casu S; Mason A; Roccarina D; Vargas V; Nilsson JE; Tsochatzis E; Augustin S; Montano-Loza AJ; Berzigotti A; Thorburn D; Genesca J; Abraldes JG
    Am J Gastroenterol; 2019 Mar; 114(3):446-452. PubMed ID: 30315285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons With Human Immunodeficiency Virus Infection and Compensated Advanced Chronic Liver Disease.
    Merchante N; Saroli Palumbo C; Mazzola G; Pineda JA; Téllez F; Rivero-Juárez A; Ríos-Villegas MJ; Maurice JB; Westbrook RH; Judge R; Guaraldi G; Schepis F; Perazzo H; Rockstroh J; Boesecke C; Klein MB; Cervo A; Ghali P; Wong P; Petta S; De Ledinghen V; Macías J; Sebastiani G
    Clin Infect Dis; 2020 Dec; 71(11):2810-2817. PubMed ID: 31813962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis.
    Jangouk P; Turco L; De Oliveira A; Schepis F; Villa E; Garcia-Tsao G
    Liver Int; 2017 Aug; 37(8):1177-1183. PubMed ID: 28160373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modified and alternative Baveno VI criteria based on age for ruling out high-risk varices in patients with compensated cirrhosis.
    Zhao L; Wang T; Guo C; Zhou L; Han P; Wang C; Ma Y; Wang J; Gao M; Li J
    Hepatol Int; 2022 Aug; 16(4):936-943. PubMed ID: 35727500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deciding Among Noninvasive Tools for Predicting Varices Needing Treatment in Chronic Liver Disease: An Analysis of Asian Cohort.
    Sharma S; Agarwal S; Gunjan D; Kaushal K; Anand A; Saraya A
    Am J Gastroenterol; 2020 Oct; 115(10):1650-1656. PubMed ID: 32516202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of hepatic elastography and Doppler indexes for predictions of esophageal varices in liver cirrhosis.
    Bintintan A; Chira RI; Bintintan VV; Nagy GA; Manzat-Saplacan MR; Lupsor-Platon M; Stefanescu H; Duma MM; Valean SD; Mircea PA
    Med Ultrason; 2015 Mar; 17(1):5-11. PubMed ID: 25745650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do we need to re-define the Baveno VI elastography criteria for compensated advanced chronic liver disease (cACLD)?
    Genescà J; Abraldes JG; Bosch J
    J Hepatol; 2021 Sep; 75(3):750-752. PubMed ID: 33892004
    [No Abstract]   [Full Text] [Related]  

  • 30. Screening varices in patients with HBV-related cirrhosis on antiviral therapy: Platelet alone or together with LSM.
    Wang B; Zhou J; Wu X; Sun Y; Li L; Li P; Li M; Jiang W; Xu M; Feng B; Xu X; Cheng J; Xie W; Han T; Wang X; Li H; Piao H; Wu S; Shi Y; Chen S; Kong Y; Ma H; Ou X; Jia J; You H
    Liver Int; 2021 Feb; 41(2):369-377. PubMed ID: 33277803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reply to: "Do we need to re-define the Baveno VI elastography criteria for compensated advanced chronic liver disease (cACLD)?".
    Papatheodoridi M; Pinzani M; Tsochatzis E
    J Hepatol; 2021 Sep; 75(3):752-753. PubMed ID: 34146649
    [No Abstract]   [Full Text] [Related]  

  • 32. Non-invasive laboratory, imaging and elastography markers in predicting varices with high risk of bleeding in cirrhotic patients.
    Petrisor A; Stanescu AMA; Papacocea IR; Panaitescu E; Peagu R; Moldoveanu AC; Fierbinteanu-Braticevici C
    Rom J Intern Med; 2021 Jun; 59(2):194-200. PubMed ID: 33544557
    [No Abstract]   [Full Text] [Related]  

  • 33. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.
    Petta S; Sebastiani G; Bugianesi E; Viganò M; Wong VW; Berzigotti A; Fracanzani AL; Anstee QM; Marra F; Barbara M; Calvaruso V; Cammà C; Di Marco V; Craxì A; de Ledinghen V
    J Hepatol; 2018 Oct; 69(4):878-885. PubMed ID: 29802949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort.
    Gaete MI; Díaz LA; Arenas A; González K; Cattaneo M; Fuster F; Henríquez R; Soza A; Arrese M; Barrera F; Arab JP; Benítez C
    Liver Int; 2020 Jun; 40(6):1427-1434. PubMed ID: 31916360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of the presence of esophageal varices using spleen stiffness measurement by transient elastography in cirrhotic patients.
    Arribas Anta J; García González M; Torres Guerrero ME; Garrido Gómez E; Rodríguez de Santiago E; López Durán S; Zaera de la Fuente C; Benita León V; Mesonero Gismero F; Martín de Argila C; Albillos Martínez A
    Acta Gastroenterol Belg; 2018; 81(4):496-501. PubMed ID: 30645918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of Baveno VI Criteria for Screening of Esophageal Varices in a Cohort of South Asian Patients with Compensated Chronic Liver Disease.
    Tadkalkar V; Devadas K; Varghese J; Cyriac R
    J Assoc Physicians India; 2020 Oct; 68(10):24-28. PubMed ID: 32978921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elastography-based screening for esophageal varices in patients with advanced chronic liver disease.
    Paternostro R; Reiberger T; Bucsics T
    World J Gastroenterol; 2019 Jan; 25(3):308-329. PubMed ID: 30686900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of spleen stiffness by magnetic resonance elastography for prediction of esophageal varices in cirrhotic patients.
    Jhang ZE; Wu KL; Chen CB; Chen YL; Lin PY; Chou CT
    Abdom Radiol (NY); 2021 Feb; 46(2):526-533. PubMed ID: 32676734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remaining challenges for the noninvasive diagnosis of esophageal varices in liver cirrhosis.
    Takehara T; Sakamori R
    Esophagus; 2020 Jan; 17(1):19-24. PubMed ID: 31620917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-invasive diagnosis of esophageal varices after Baveno VI.
    Moctezuma Velázquez C; Abraldes JG
    Turk J Gastroenterol; 2017 May; 28(3):159-165. PubMed ID: 28492370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.